225 related articles for article (PubMed ID: 26512957)
21. Bone morphogenic protein (BMP) signaling up-regulates neutral sphingomyelinase 2 to suppress chondrocyte maturation via the Akt protein signaling pathway as a negative feedback mechanism.
Kakoi H; Maeda S; Shinohara N; Matsuyama K; Imamura K; Kawamura I; Nagano S; Setoguchi T; Yokouchi M; Ishidou Y; Komiya S
J Biol Chem; 2014 Mar; 289(12):8135-50. PubMed ID: 24505141
[TBL] [Abstract][Full Text] [Related]
22. Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death.
Levy M; Khan E; Careaga M; Goldkorn T
Am J Physiol Lung Cell Mol Physiol; 2009 Jul; 297(1):L125-33. PubMed ID: 19395669
[TBL] [Abstract][Full Text] [Related]
23. [Advance in research on regulatory mechanism and functions of neutral sphingomyelinse 2].
Zhang L; Guo J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Oct; 35(5):581-5. PubMed ID: 24183051
[TBL] [Abstract][Full Text] [Related]
24. The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes.
Guo BB; Bellingham SA; Hill AF
J Biol Chem; 2015 Feb; 290(6):3455-67. PubMed ID: 25505180
[TBL] [Abstract][Full Text] [Related]
25. Interaction of Synaptosomal-Associated Protein 25 with Neutral Sphingomyelinase 2: Functional Impact on the Sphingomyelin Pathway.
Won JH; Jeon HJ; Kim SK; Shin IC; Jang JM; Ha HC; Back MJ; Kim DK
Neuroscience; 2020 Feb; 427():1-15. PubMed ID: 31765623
[TBL] [Abstract][Full Text] [Related]
26. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD).
Wang G; Dinkins M; He Q; Zhu G; Poirier C; Campbell A; Mayer-Proschel M; Bieberich E
J Biol Chem; 2012 Jun; 287(25):21384-95. PubMed ID: 22532571
[TBL] [Abstract][Full Text] [Related]
27. Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase.
Hofmann K; Tomiuk S; Wolff G; Stoffel W
Proc Natl Acad Sci U S A; 2000 May; 97(11):5895-900. PubMed ID: 10823942
[TBL] [Abstract][Full Text] [Related]
28. Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2.
Clarke CJ; Truong TG; Hannun YA
J Biol Chem; 2007 Jan; 282(2):1384-96. PubMed ID: 17085432
[TBL] [Abstract][Full Text] [Related]
29. Anterograde and retrograde transport of neutral sphingomyelinase-2 between the Golgi and the plasma membrane.
Milhas D; Clarke CJ; Idkowiak-Baldys J; Canals D; Hannun YA
Biochim Biophys Acta; 2010 Dec; 1801(12):1361-74. PubMed ID: 20713176
[TBL] [Abstract][Full Text] [Related]
30. Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.
Montfort A; Bertrand F; Rochotte J; Gilhodes J; Filleron T; Milhès J; Dufau C; Imbert C; Riond J; Tosolini M; Clarke CJ; Dufour F; Constantinescu AA; Junior NF; Garcia V; Record M; Cordelier P; Brousset P; Rochaix P; Silvente-Poirot S; Therville N; Andrieu-Abadie N; Levade T; Hannun YA; Benoist H; Meyer N; Micheau O; Colacios C; Ségui B
Cancer Immunol Res; 2021 May; 9(5):568-582. PubMed ID: 33727246
[TBL] [Abstract][Full Text] [Related]
31. Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies.
Corcoran CA; He Q; Ponnusamy S; Ogretmen B; Huang Y; Sheikh MS
Mol Cancer Res; 2008 May; 6(5):795-807. PubMed ID: 18505924
[TBL] [Abstract][Full Text] [Related]
32. Stress-induced sphingolipid signaling: role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation.
Devillard R; Galvani S; Thiers JC; Guenet JL; Hannun Y; Bielawski J; Nègre-Salvayre A; Salvayre R; Augé N
PLoS One; 2010 Mar; 5(3):e9826. PubMed ID: 20352118
[TBL] [Abstract][Full Text] [Related]
33. Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation.
Wu D; Ozaki T; Yoshihara Y; Kubo N; Nakagawara A
J Biol Chem; 2013 Jan; 288(2):1353-64. PubMed ID: 23148227
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53.
Taha TA; Osta W; Kozhaya L; Bielawski J; Johnson KR; Gillanders WE; Dbaibo GS; Hannun YA; Obeid LM
J Biol Chem; 2004 May; 279(19):20546-54. PubMed ID: 14988393
[TBL] [Abstract][Full Text] [Related]
35. Neutral Sphingomyelinase 2 Mediates Oxidative Stress Effects on Astrocyte Senescence and Synaptic Plasticity Transcripts.
Zhu Z; Quadri Z; Crivelli SM; Elsherbini A; Zhang L; Tripathi P; Qin H; Roush E; Spassieva SD; Nikolova-Karakashian M; McClintock TS; Bieberich E
Mol Neurobiol; 2022 May; 59(5):3233-3253. PubMed ID: 35294731
[TBL] [Abstract][Full Text] [Related]
36. Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation.
Airola MV; Shanbhogue P; Shamseddine AA; Guja KE; Senkal CE; Maini R; Bartke N; Wu BX; Obeid LM; Garcia-Diaz M; Hannun YA
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5549-E5558. PubMed ID: 28652336
[TBL] [Abstract][Full Text] [Related]
37. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
38. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.
Shamseddine AA; Airola MV; Hannun YA
Adv Biol Regul; 2015 Jan; 57():24-41. PubMed ID: 25465297
[TBL] [Abstract][Full Text] [Related]
39. Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium.
Kim SK; Ahn KH; Ji JE; Choi JM; Jeon HJ; Jung SY; Jung KM; Kim DK
Cell Signal; 2010 May; 22(5):865-70. PubMed ID: 20096352
[TBL] [Abstract][Full Text] [Related]
40. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity.
Yoshida M; Shiojima I; Ikeda H; Komuro I
J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
